Regeneron Pharmaceuticals (NASDAQ:REGN) outlined its C5 complement development strategy in an investor roundtable focused on cemdisiran, an siRNA targeting C5, and pozelimab, a C5-targeting antibody ...

Combining deep domain knowledge with advanced engineering, Chandra Shekhar Pareek has redefined quality in the insurance ...

London Stock Exchange Q1 revenue hits a record +9.8%, driven by Markets/Risk Intelligence & subscriptions. See more on LDNXF ...

Cintra People includes payroll functionality, so you don’t have to switch to another system to tackle the finances, and it ...

At Cloud Next this week in Las Vegas, Google made its case this week that it has all the pieces — literally the entire “stack ...

Need better stock visibility and smoother fulfillment? Here are the best inventory management software options we've tested ...

Automated trading has transformed the way people participate in financial markets. By combining speed, efficiency, and ...

Looking for better ways to track and present your SEO performance? We've tested the best SEO reporting software, including ...

A previously undocumented state-backed threat actor named GopherWhisper is using a Go-based custom toolkit and legitimate ...

The Indianapolis-based insurer raised its 2026 earnings guidance after posting a better first quarter than Wall Street ...

The U.S. Environmental Protection Agency proposed adding microplastics and pharmaceuticals to a list of contaminants in ...

Premium hikes, plan redesigns and other efforts from the Minnesota-based company to wrangle medical spending bore fruit in the first quarter. UnitedHealth’s stock jumped accordingly.